Ventripoint Diagnostics Ltd. (VPTDF)
OTCMKTS · Delayed Price · Currency is USD
0.0875
-0.0049 (-5.28%)
Feb 12, 2026, 3:13 PM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of $16.01 million as of February 12, 2026. Its market cap has increased by 41.90% in one year.
Market Cap
16.01M
Enterprise Value
17.68M
Revenue
126.09K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 16.01M, an increase of 134.67%. That is a compound annual growth rate of 4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 16.06M | -6.53% |
| Dec 31, 2025 | 17.18M | 52.58% |
| Dec 31, 2024 | 11.26M | -67.86% |
| Dec 29, 2023 | 35.03M | 11.97% |
| Dec 30, 2022 | 31.29M | -26.23% |
| Dec 31, 2021 | 42.41M | 572.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guided Therapeutics | 33.69M |
| Vivos | 32.75M |
| PetVivo Holdings | 27.73M |
| Linike Medical Group | 17.16M |
| REMSleep Holdings | 12.09M |
| QHSLab | 11.42M |
| ALR Technologies SG | 9.53M |
| Family Office of America | 8.61M |